Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Bone. 2019 May 2;127:91–103. doi: 10.1016/j.bone.2019.04.019

Table 1:

Serum and urine measures of kidney disease status at study end

6 mo 18 mo 24 mo
Sham CKD Sham CKD Sham CKD
Serum urea (mg/dL) 87.9 ± 5.84 152 ± 15.8 73.5 ± 6.76 212 ± 15.9 76.3 ± 11.5 188 ± 21.9
Age: NS
CKD: p < 0.001
Age × CKD: NS

Urine urea (mg/dL) 8.94E3 ± 1.36E3 5.39E3 ± 0.599E3 8.28E3 ± 1.05E3 5.55E3 ± 0.633E3 9.48E3 ± 0.792E3 5.52E3 ± 0.846E3
Age: NS
CKD: p < 0.001
Age × CKD: NS

Phosphate (mg/dL) 9.22 ± 1.77 12.7 ± 0.682 9.63 ± 0.890 12.3 ± 0.960 9.53 ± 0.830 11.9 ± 0.324
Age: NS
CKD: p = 0.001
Age × CKD: NS

Calcium (mg/dL) 9.43 ± 0.282 7.50 ± 1.37 8.25 ± 0.554 9.16 ± 0.791 7.14 ± 1.14 8.78 ± 0.285
Age: NS
CKD: NS
Age × CKD: NS

Parathyroid hormone (mg/dL) 165 ± 51.9 302 ± 113 180 ± 42.1 464 ± 76.3 228 ± 38.5 490 ± 114
Age: NS
CKD: p = 0.002
Age × CKD: NS

Data are presented as mean +/− standard error of the mean. P-values for main effects of age and CKD as well as their interaction are reported in the left column. Serum urea, phosphate, and calcium were measured for 6 mo /Sham (n = 6), 6 mo/CKD (n = 7), 18 mo/Sham (n = 8), 18 mo/CKD (n = 10), 24 mo/Sham (n = 8), 24 mo/CKD (n = 8). PTH was assessed for 6 mo/Sham (n = 5), 6 mo/CKD (n = 5), 18 mo/Sham (n = 4), 18 mo/CKD (n = 6), 24 mo/Sham (n = 5), 24 mo/CKD (n = 5). Urine urea was measured for 6 mo /Sham (n = 6), 6 mo/CKD (n = 7), 18 mo/Sham (n = 7), 18 mo/CKD (n = 9), 24 mo/Sham (n = 7), 24 mo/CKD (n = 6).